Community/Retail

Selective reporting and underrepresentation distort biomedical evidence, affecting pharmacy practice

The supplements were also linked to improvements in pain and disease activity markers.

Patients with ASCVD face increased cardiovascular risks post revascularization, yet many miss timely LDL-C testing and treatment, highlighting critical care gaps.

FDA approves lonapegsomatropin for once-weekly treatment of growth hormone deficiency, offering a promising alternative for improved patient adherence and outcomes.

Explore pharmacy policy updates and insights for July 2025.

Many factors contribute to vaccine skepticism, including trust, convenience, and fear.

GLP-1 receptor agonists show promise in improving survival rates for older patients with cancer who have type 2 diabetes (T2D), highlighting their potential in oncology.

Essential tips on prenatal vitamins, ovulation kits, pregnancy tests, and emergency contraception for effective family planning and pregnancy preparation.

There is no established routine monitoring schedule, but close observation is critical.

Namrata Shah, MD, discusses the groundbreaking efficacy and patient-centered potential of twice-yearly lenacapavir for HIV preexposure prophylaxis (PrEP), supported by pivotal data from the PURPOSE trials.

RSV outbreaks pose significant risks globally, highlighting the urgent need for targeted vaccination and treatment strategies to protect vulnerable populations.

Insights from the American Diabetes Association 85th Scientific Sessions.

Conversely, Medicaid enrollees experienced widening gaps of pneumococcal vaccination uptake, likely driven by socioeconomic obstacles.

GLP-1 receptor agonists show promise in alleviating PCOS symptoms, including weight loss and menstrual regulation, despite needing further research.

Pharmacy technicians evolve into vital health care roles, enhancing patient care and operational efficiency through structured career advancement pathways.

CDC's ACIP recommends removing thimerosal from flu vaccines, igniting debate on vaccine safety and fueling antivaccine sentiments amid public health concerns.

In 2 clinical trials, oveporexton shows promise in treating narcolepsy type 1 (NT1), paving the way for potential FDA approval.

There were also no observed differences in retention rates or safety among patients with ankylosing spondylitis.

Sherie Loy-Helm, PharmD, has built a thriving independent pharmacy rooted in community, compassion, and outstanding service.

Particularly during summer months, counsel patients about sunscreen recommendations and drug-induced photosensitivity prevention strategies.

A Danish study confirms no link between aluminum in childhood vaccines and chronic diseases, reinforcing vaccine safety amid rising skepticism.

Adam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.

Even patients who are confident in their abilities often use incorrect technique

Carrie Harney, JD, of US Pharmacopeia (USP) discusses how proposed tariffs could impact generic drug supply chains, sterile injectable shortages, and pharmacy operations, underscoring the need for policy incentives and manufacturing diversification.

Results from the ZENITH trial show sotatercept's promise for pulmonary arterial hypertension treatment.

The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.

In the double-blind portion of Vibrance-1, alixorexton improved wakefulness while eliciting broad benefits in patient-reported outcomes.